HIF1A and breast carcinoma: By reducing reactive oxygen species (ROS), EGCG may inhibit HIF-1α protein accumulation, thereby facilitating HIF-1α protein degradation via the VHL-mediated ubiquitin-proteasome pathway, although direct evidence in breast cancer cells remains limited [54,55,56].